ENABLING MEANINGFUL METABOLIC DISEASE RESEARCH

Clear efficacy signals are as crucial as keeping research representative and reasonable in this complex field. Worldwide delivers studies that make sense for everyone

LEVERAGING OUR CLINICAL EXPERTISE

Whether your indication has millions of potential participants across the globe or just dozens, know that Worldwide’s dedicated team and global network of trusted partner sites can offer the expertise you need to succeed. Our extensive group of subject matter experts in both rare and common endocrine and metabolic conditions help get studies done right. 

RAFAL ZIECINA, MD, PHD

EXECUTIVE DIRECTOR, SCIENTIFIC SOLUTIONS, CARDIOVASCULAR, ENDOCRINE & METABOLIC

With more than 22 years of experience in the World of pharmaceuticals and research, Dr. Ziecina serves as an NAFLD/NASH scientific advisor focused on filing strategies, regulatory and safety strategies. He excels in writing protocols and drug development plans and has extensive experience in study design and medical monitoring for clinical programs.

SHERILYN ADCOCK, RPH, PHD

CHIEF SCIENTIFIC OFFICER, EARLY PHASE DEVELOPMENT

Dr. Adcock has more than 30 years of clinical research experience, much of which has focused on Phase I/II drug development. She has been with Worldwide for 20 years, evaluating scientific, clinical, design and logistical expertise for early clinical development projects. She has also served as Principal or Sub-Investigator on more than 200 clinical trials. Her expertise in pharmacology, bioanalysis and drug development gives every program she works on a competitive edge.

 

  • expert image
  • expert image

Human capital that brings clarity to complexity 

At Worldwide, we understand that our greatest strength is our personnel—our expert teams around the world that craft unparalleled design and logistics solutions for even the most challenging studies. When you start with a better CRO team, you get a better study experience for the life of your program.

Metabolic Experience

  • Acid Sphingomyelinase Deficiency
  • (Niemann-Pick Disease) Type C
  • Acromegaly
  • Chronic Kidney Disease (Chronic Renal Failure)
  • Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)
  • Congenital Hyperinsulinemic Hypoglycemia
  • Diabetes Type 1
  • Diabetes Type 2
  • Dyslipidemia
  • Fabry Disease
  • Familial Chylomicronemia (Type I Hyperlipoproteinemia)
  • Fatty Acid Biosynthesis Disorders
  • Gaucher’s Disease
  • Growth Hormone Deficiency
  • Hypercholesterolemia
  • Insulin-induced Severe Hypoglycemia
  • Kidney Disease
  • Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease)
  • Mucopolysaccharidoses
  • Non-Alcoholic Steatohepatitis (NASH)
  • Obesity
  • Phenylketonuria
  • Proteus Syndrome
  • Type 1 Diabetes (Juvenile Diabetes)

Our Dedicated Team